Hemoglobin A1c Testing Devices Market Size Was Valued at USD 1.4 Billion in 2023, and is Projected to Reach USD 2.87 Billion by 2032, Growing at a CAGR of 7.7% from 2024-2032. The term Hemoglobin A1c (HbA1c) Testing Devices Market encompasses the businesses that design, manufacture, and market products employed in testing the Hemoglobin A1c levels that is crucial in preliminary diagnosing and monitoring of the Diabetes. HbA1c or glycosylated haemoglobin gives a perspective of the average blood glucose values in the preceding two to three months and hence is more important in evaluating duration control of hyperglycaemia in diabetics. Point of care devices, laboratory based analysers and portable testing devices form the market of HbA1c testing devices that offer the physicians as well as the patient’s quick and accurate results for glycaemic control.